Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site

被引:36
作者
Chen, Min-Chi [2 ,3 ]
Chen, Ping-Tsung [1 ,4 ,5 ]
Chan, Chunghuang Hubert [1 ,6 ]
Yang, Cheng-Ta [7 ]
Chen, Chih-Cheng [1 ,6 ]
Huang, Cih-En [1 ]
Lu, Chang-Hsien [1 ,6 ]
Lee, Kuan-Der [1 ,4 ,5 ,6 ]
机构
[1] Chang Gung Mem Hosp, Dept Hematol & Oncol, Pu Tz City 613, Chiayi, Taiwan
[2] Chang Gung Univ, Dept Publ Hlth, Sch Med, Tao Yuan, Taiwan
[3] Chang Gung Univ, Biostat Consulting Ctr, Sch Med, Tao Yuan, Taiwan
[4] Chang Gung Univ, Dept Med, Tao Yuan, Taiwan
[5] Chang Gung Univ, Inst Clin Med Sci, Tao Yuan, Taiwan
[6] Chang Gung Inst Technol, Dept Nursing, Chiayi, Taiwan
[7] Chang Gung Mem Hosp, Dept Thorac Med, Linkou, Taiwan
关键词
Head and neck cancer; Second cancer; Betel quid chewing; SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; NASOPHARYNGEAL CARCINOMA; PRIMARY MALIGNANCIES; HUMAN-PAPILLOMAVIRUS; BETEL QUID; POOLED ANALYSIS; BREAST-CANCER; ORAL-CAVITY; SURVIVAL;
D O I
10.1007/s00432-010-0865-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Second primary cancer is prevalent in patients with head and neck cancer (HNC), for which esophagus and lung are the most usual sites, associated with an extremely poor prognosis. However, information regarding the actual risk of second primary esophageal or lung cancer in South-east Asia, the betel-quid chewing area, has been restricted to data from single-institutions. We have therefore conducted a population-based study to evaluate the incidence, risk, and developmental time of second esophageal or lung cancer in HNC patients. Standardized incidence ratios (SIRs) and cumulative incidences were calculated for second primary esophageal or lung cancer using a database from the Taiwan Cancer Registry that included 63,720 cases having an initial diagnosis of HNC. The risk of second esophageal cancer was increased in patients with oral/pharyngeal (SIR = 8.71, 95% CI 7.55-10.01) and laryngeal (SIR = 4.65, 95% CI 3.37-6.27) cancers, whereas second lung risk was increased in patients with laryngeal (SIR = 2.05, 95% CI 1.69-2.45) and oral/pharyngeal (SIR = 1.56, 95% CI 1.34-1.80) cancers. The risk excess was prominent for patients with a follow-up interval < 5 years and a first primary cancer diagnosed at age < 50. Nevertheless, patients with nasopharyngeal carcinoma were not associated with an excess risk in second esophageal or lung cancer. The present dataset provides definite evidence that there is a substantial excess risk of second primary esophageal or lung cancer for the index tumors of oral cavity, pharynx and larynx. The absence of risk excess found in nasopharyngeal carcinoma is also compatible with the existing knowledge that it might have an entirely distinctive etiology.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 47 条
[1]  
[Anonymous], 2005, CANC REG ANN REP
[2]  
Breslow NE, 1987, IARC SCI PUBL, P82
[3]   The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003) [J].
Chen, M. -C. ;
Feng, I. -J. ;
Lu, C. -H. ;
Chen, C. -C. ;
Lin, J. -T. ;
Huang, S. -H. ;
Lee, K. -D. .
ANNALS OF ONCOLOGY, 2008, 19 (06) :1180-1186
[4]   Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men [J].
Chien, YC ;
Chen, JY ;
Liu, MY ;
Yang, HI ;
Hsu, MM ;
Chen, CJ ;
Yang, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (26) :1877-1882
[5]   Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries [J].
Chuang, Shu-Chun ;
Scelo, Ghislaine ;
Tonita, Jon M. ;
Tamaro, Sharon ;
Jonasson, Jon G. ;
Kliewer, Erich V. ;
Hemminki, Kari ;
Weiderpass, Elisabete ;
Pukkala, Eero ;
Tracey, Elizabeth ;
Friis, Soren ;
Pompe-Kirn, Vera ;
Brewster, David H. ;
Martos, Carmen ;
Chia, Kee-Seng ;
Boffetta, Paolo ;
Brennan, Paul ;
Hashibe, Mia .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (10) :2390-2396
[6]   2ND MALIGNANCIES IN PATIENTS WHO HAVE HEAD AND NECK-CANCER - INCIDENCE, EFFECT ON SURVIVAL AND IMPLICATIONS BASED ON THE RTOG EXPERIENCE [J].
COOPER, JS ;
PAJAK, TF ;
RUBIN, P ;
TUPCHONG, L ;
BRADY, LW ;
LEIBEL, SA ;
LARAMORE, GE ;
MARCIAL, VA ;
DAVIS, LW ;
COX, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (03) :449-456
[7]   Case-control study of human papillomavirus and oropharyngeal cancer [J].
D'Souza, Gypsyamber ;
Kreimer, Aimee R. ;
Viscidi, Raphael ;
Pawlita, Michael ;
Fakhry, Carole ;
Koch, Wayne M. ;
Westra, William H. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) :1944-1956
[8]  
DAY GL, 1994, ORAL ONCOL, V30B, P381
[9]   A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes [J].
Freedman, Neal D. ;
Abnet, Christian C. ;
Leitzmann, Michael F. ;
Mouw, Traci ;
Subar, Amy F. ;
Hollenbeck, Albert R. ;
Schatzkin, Arthur .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (12) :1424-1433
[10]   Evidence for a causal association between human papillomavirus and a subset of head and neck cancers [J].
Gillison, ML ;
Koch, WM ;
Capone, RB ;
Spafford, M ;
Westra, WH ;
Wu, L ;
Zahurak, ML ;
Daniel, RW ;
Viglione, M ;
Symer, DE ;
Shah, KV ;
Sidransky, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (09) :709-720